A Novel Breath Test For Mitochondrial Dysfunction
Tech ID: 23538 / UC Case 2011-778-0
Mitochondrial dysfunction is being increasingly implicated in many diseases, including neurodegenerative disorders, heart disease and diabetes, and also in the normal aging process. Current methods to identify mitochondrial dysfunction require invasive techniques such as tissue biopsy, which are painful and provide only limited amounts of test material. New, less invasive methods to assess mitochondrial dysfunction would provide researchers and medical professionals with innovative diagnostic options.
Researchers at the University of California, Irvine have developed a novel, non-invasive breath test that can be used to diagnose mitochondrial dysfunction or monitor patient response to therapy. The breath test is painless, cost-effective, and can be repeatedly administered to patients.
The breath test may be used to identify mitochondrial dysfunction and determine effectiveness of various therapies. It may be used in virtually any medical or research setting.
Mitochondrial dysfunction, Breath test, Neurodegenerative, Heart disease, Diabetes, Aging
PEOPLE WHO VIEWED THIS ALSO VIEWED THESE TECHNOLOGIES BY OTHER INVENTORS
- Encapsulated Sensors For Bioassays And Diagnostics
- Self-Healing Polymer Via Olefin Metathesis
- Micro implantable neural interface with electrophysiological and fluid delivery capability
- Breath Analysis for the Diagnosis and Monitoring of Sepsis and Other Serious Inflammatory States
- Quantitative 3D-Endoscopy Using Stereo CMos-Camera Pairs